Document is current
Any future updates will be listed below
-
Authors
Pisani, Ilaria
Melita, Giusi
de Souza, Patricia Borges
Galimberti, Stefania
Savino, Angela Maria
Sarno, Jolanda
Landoni, Beatrice
Crippa, Stefano
Gotti, Elisa
Cuofano, Carolina
Pedrini, Olga
Capelli, Chiara
Matera, Giada
Belotti, Daniela
Cesana, Stefania
Cabiati, Benedetta
Quaroni, Michele
Colombo, Valentina
Mazza, Massimiliano
Vergani, Barbara
Gaimari, Anna
Nicolini, Fabio
Tazzari, Marcella
Bocchini, Martine
Serafini, Marta
Rambaldi, Alessandro
Rambaldi, Benedetta
Dastoli, Giuseppe
Biondi, Andrea
Gaipa, Giuseppe https://orcid.org/0000-0002-1006-5946
Introna, Martino
Golay, Josée
Tettamanti, Sarah https://orcid.org/0000-0002-7327-418X
-
Funding
Funding for this research was provided by:
Fondazione AIRC per la ricerca sul cancro ETS (21147, 30974)
Fondazione Regionale per la Ricerca Biomedica (CP2_10/2018)
Ministero della Salute (CN3 - National Center for Gene Therapy and Drugs based on RNA Technology, Hub Life Science– Terapia Avanzata (LSH-TA) PNC-E3-2022-23683269, Research Project on CAR-T cells for hematological malignancies and solid tumors", as part of the Alliance Against Cancer (ACC) network initiative-grant number: RCR-2023-23684268)
- License Information
-
More Information
Article History
Received: 18 January 2025
Accepted: 25 March 2025
First Online: 19 May 2025
Declarations
:
: The in vivo studies were approved by the Italian Ministry of Health. Procedures involving animals were conformed with protocols approved by the Milano-Bicocca University in compliance with national and international law and policies. All in vivo experiments were conducted at the University of Milano-Bicocca.
: Not applicable.
: The authors declare that they have no competing interests.
